2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
6
Lung Neoplasms
5
Glioblastoma
4
Urinary Bladder Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Brain Neoplasms
3
Pancreatic Neoplasms
2
Lung Diseases
2
Glioma
2
Astrocytoma
2
Uterine Cervical Neoplasms
1
Tuberculosis, Pulmonary
1
Thyroid Nodule
1
Stomach Neoplasms
1
Solitary Pulmonary Nodule
1
Pulmonary Fibrosis
1
Pulmonary Embolism
1
Pulmonary Disease, Chronic Obstructive
1
Pulmonary Arterial Hypertension
1
Prostatic Neoplasms
1
Pleural Neoplasms
1
Pancreatic Cyst
1
Oropharyngeal Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Multiple Pulmonary Nodules
1
Mouth Neoplasms
1
Mesothelioma
1
Medication Adherence
1
Interventions
Gemcitabine
30
Mitomycin
25
BCG Vaccine
13
Docetaxel
10
Epirubicin
6
erdafitinib
5
durvalumab
5
dodecyl maltoside
5
Radiotherapy
5
Cystoscopy
5
apaziquone
4
ALT-803
4
tislelizumab
3
5-aminolevulinic acid hexyl ester
3
viscum album peptide
2
pembrolizumab
2
disitamab vedotin
2
avelumab
2
VB4-845
2
Therapeutics
2
Imiquimod
2
Hyaluronic Acid
2
Administration, Intravesical
2
1-phenyl-3,3-dimethyltriazene
2
vocimagene amiretrorepvec
1
valrubicin
1
tremelimumab
1
toripalimab
1
pirarubicin
1
pemigatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Drug Delivery Systems
×
Clear all
NCT02660645
2025-12-18
BLCCR
Photocure
Recruiting
4,400 enrolled